✦ LIBER ✦

High-dose chemotherapy and autologous stem cell support followed by post-transplant doxorubicin and taxol as initial therapy for metastatic breast cancer: hematopoietic tolerance and efficacy

✍ Scribed by deMagalhaes-Silverman, M; Hammert, L; Lembersky, B; Lister, J; Rybka, W; Ball, E

Book ID: 110010578
Publisher: Nature Publishing Group
Year: 1998
Tongue: English
Weight: 48 KB
Volume: 21
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1701263

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose chemotherapy and autologous he

High-dose chemotherapy and autologous hematopoietic stem cell transplantation for metastatic breast cancer: a therapy whose time has passed

✍ Vogl, D T; Stadtmauer, E A 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 84 KB

Interleukin-2 and granulocyte–macrophage

Interleukin-2 and granulocyte–macrophage–colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer

✍ Yee Chung Cheng; Gabriela Rondón; Leah F. Sanchez; John D. McMannis; Daniel R. C 📂 Article 📅 2009 🏛 Carden Jennings Publishing 🌐 English ⚖ 210 KB

Double high-dose chemotherapy with adria

Double high-dose chemotherapy with adriamycin, paclitaxel, cyclophosphamide, and thiotepa followed by autologous peripheral blood stem cell transplantation in women with metastatic breast cancer

✍ Herbert G. Sayer; Kristina Schilling; Tobias Vogt; Kerstin Blumenstengel; Miriam 📂 Article 📅 2003 🏛 Springer-Verlag 🌐 English ⚖ 190 KB

Adjuvant treatment of high-risk stage II

Adjuvant treatment of high-risk stage II breast cancer with doxorubicin followed by high-dose chemotherapy and autologous stem-cell transplantation: a single-institution experience with 132 consecutive patients

✍ Stemmer, S M; Hardan, I; Raz, H; Adamou, A K; Inbar, M; Gottfried, M; Merrick, Y 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 144 KB

The psychosocial experience of women tre

The psychosocial experience of women treated for breast cancer by high-dose chemotherapy supported by autologous stem cell transplant: a qualitative analysis of support groups

✍ R. Feigin; A. Greenberg; H. Ras; Y. Hardan; S. Rizel; T. Ben Efraim; S.M. Stemme 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 2 views

Autologous bone marrow transplantation (AuBMT) is probably among the most aggressive of physical treatments endured by cancer patients. High-risk breast cancer patients who choose this therapy face prolonged, agonizing and life-threatening interventions that are no less arduous than confronting the

High-dose intravenous melphalan and auto

High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trial

✍ Sanchorawala, V; Wright, D G; Seldin, D C; Falk, R H; Finn, K T; Dember, L M; Be 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 161 KB